| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Advances in Brief |
Department of Biochemistry, Hong Kong University of Science and Technology, Clear Water Bay, Kowloon, Hong Kong
Transforming growth factor-
(TGF-) inhibits cell proliferation in many cell types, and acquisition of TGF- resistance has been linked to tumorigenesis. One class of proteins that plays a key role in the TGF- signal transduction pathway is the SMAD protein family. MDM2, a key negative regulator of p53, has recently been shown to suppress TGF--induced growth arrest in a p53-independent manner. Here we show that MDM2 and the structurally related protein MDMX can inhibit the transcriptional activity of ectopically expressed SMAD1, SMAD2, SMAD3, and SMAD4. Immunofluorescence staining indicated that ectopically expressed SMAD4 was present in both the cytoplasm and nucleus, and MDM2 and MDMX were localized mainly to the nucleus and cytoplasm, respectively. When SMAD4 was coexpressed with either MDM2 or MDMX, nuclear accumulation of SMAD4 was strikingly inhibited. We have no evidence that SMAD4 binds directly to MDM2 or MDMX; hence, the inactivation and nuclear exclusion of SMAD4 by MDM2/MDMX may involve other indirect mechanisms.
This article has been cited by other articles:
|
|
 |
|
  T. K. Fung, H. T. Ma, and R. Y.C. Poon Specialized Roles of the Two Mitotic Cyclins in Somatic Cells: Cyclin A as an Activator of M Phase-promoting Factor Mol. Biol. Cell, May 1, 2007; 18(5): 1861 - 1873. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. M. Chan and R. Y.C. Poon The p53 Isoform {Delta}p53 Lacks Intrinsic Transcriptional Activity and Reveals the Critical Role of Nuclear Import in Dominant-Negative Activity Cancer Res., March 1, 2007; 67(5): 1959 - 1969. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T.-H. Cheng and S. N. Cohen Human MDM2 Isoforms Translated Differentially on Constitutive versus p53-Regulated Transcripts Have Distinct Functions in the p53/MDM2 and TSG101/MDM2 Feedback Control Loops Mol. Cell. Biol., January 1, 2007; 27(1): 111 - 119. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Datta, M. Bellon, U. Sinha-Datta, A. Bazarbachi, Y. Lepelletier, D. Canioni, T. A. Waldmann, O. Hermine, and C. Nicot Persistent inhibition of telomerase reprograms adult T-cell leukemia to p53-dependent senescence Blood, August 1, 2006; 108(3): 1021 - 1029. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. M. Chan, W. Y. Siu, A. Lau, and R. Y. C. Poon How Many Mutant p53 Molecules Are Needed To Inactivate a Tetramer? Mol. Cell. Biol., April 15, 2004; 24(8): 3536 - 3551. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. A. Steinman, E. Burstein, C. Lengner, J. Gosselin, G. Pihan, C. S. Duckett, and S. N. Jones An Alternative Splice Form of Mdm2 Induces p53-independent Cell Growth and Tumorigenesis J. Biol. Chem., February 6, 2004; 279(6): 4877 - 4886. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. P. H. Chow, W. Y. Siu, H. T. B. Ho, K. H. T. Ma, C. C. Ho, and R. Y. C. Poon Differential Contribution of Inhibitory Phosphorylation of CDC2 and CDK2 for Unperturbed Cell Cycle Control and DNA Integrity Checkpoints J. Biol. Chem., October 17, 2003; 278(42): 40815 - 40828. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Li, L. Chen, and J. Chen DNA Damage Induces MDMX Nuclear Translocation by p53-Dependent and -Independent Mechanisms Mol. Cell. Biol., November 1, 2002; 22(21): 7562 - 7571. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Migliorini, E. L. Denchi, D. Danovi, A. Jochemsen, M. Capillo, A. Gobbi, K. Helin, P. G. Pelicci, and J.-C. Marine Mdm4 (Mdmx) Regulates p53-Induced Growth Arrest and Neuronal Cell Death during Early Embryonic Mouse Development Mol. Cell. Biol., August 1, 2002; 22(15): 5527 - 5538. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Alarcon-Vargas and Z.'e. Ronai p53-Mdm2--the affair that never ends Carcinogenesis, April 1, 2002; 23(4): 541 - 547. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Migliorini, D. Danovi, E. Colombo, R. Carbone, P. G. Pelicci, and J.-C. Marine Hdmx Recruitment into the Nucleus by Hdm2 Is Essential for Its Ability to Regulate p53 Stability and Transactivation J. Biol. Chem., February 22, 2002; 277(9): 7318 - 7323. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
X. Q. Wang, W. M. Ongkeko, A. W. S. Lau, K. M. Leung, and R. Y. C. Poon A Possible Role of p73 on the Modulation of p53 Level through MDM2 Cancer Res., February 1, 2001; 61(4): 1598 - 1603. [Abstract] [Full Text]
|
|
|
|
|
|
S. W. Blain and J. Massague Different Sensitivity of the Transforming Growth Factor-beta Cell Cycle Arrest Pathway to c-Myc and MDM-2 J. Biol. Chem., October 6, 2000; 275(41): 32066 - 32070. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Cell Growth & Differentiation |
